Springstubb Brendan B
SEC Form 4 insider trading activity
Springstubb Brendan B has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: Jun 8, 2026.
On the most recent filing, Springstubb Brendan B is listed as Director at Evolent Health, Inc. Inside the rolling window, Springstubb Brendan B reported 1 open-market purchase totaling $38K in EVH and no open-market sales.
Companies traded
Other insiders at EVH
Insider Buying
$38K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Springstubb Brendan B made?
Springstubb Brendan B has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company since 2025.
Which companies does Springstubb Brendan B trade?
Springstubb Brendan B has filed SEC Form 4 disclosures for 1 company, including EVH.
When was Springstubb Brendan B's most recent SEC Form 4 filing?
Springstubb Brendan B's most recent SEC Form 4 filing on Tracefour is dated Jun 8, 2026.
What is Springstubb Brendan B's total buy and sell value in the current window?
Inside the rolling retention window, Springstubb Brendan B bought $38K and sold $0 based on SEC Form 4 filings.
What was Springstubb Brendan B's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 10,000 EVH shares on 2025-11-18, worth $38K, per SEC Form 4 filings.